PT - JOURNAL ARTICLE AU - Cappiello, Jhaymie AU - Bremenour, Carla AU - Boyle, Jason AU - Lumbard, Jessica AU - Ghadimi, Kamrouz TI - Continuous Aerosol Medication Therapy in an <em>in vitro</em> High-Flow System Using Wire Mesh Technology AID - 10.1101/2020.02.10.20020719 DP - 2020 Jan 01 TA - medRxiv PG - 2020.02.10.20020719 4099 - http://medrxiv.org/content/early/2020/02/11/2020.02.10.20020719.short 4100 - http://medrxiv.org/content/early/2020/02/11/2020.02.10.20020719.full AB - BACKGROUND Jet nebulizers are commonly used to provide continuous aerosolized medication therapy (CAMT). We observed the function of our CAMT system that utilizes the Aeroneb Solo nebulizer system (Aerogen Ltd, Galway, Ireland). METHODS: An observational study was performed on 2 CAMT systems with 15 Aeroneb nebulizers for each system. CAMT was simulated for 1, 2 and 3 hours. Continuous nebulization was monitored and residual volumes were recorded at the end of each simulation. Our primary endpoint was established as intermittent nebulization observed by nebulizer filling of &gt; 1 ml during CAMT simulation. Secondary endpoint was a residual volume of &lt; 0.1 ml.RESULTS Out of 30 simulations in two arms, a fluid level was observed to accumulate intermittently in three nebulizers with a residual volume of 0.7 mls in one of these three. This produced a total success rate of 90%, Arm-A 80%, Arm B-100%, for our primary endpoint. Our secondary endpoint was achieved in 29 of the 30 nebulizers for an overall 97% success rate, Arm A-93%, Arm B-100%. CONCLUSION: Our Aerogen Solo CAMT system successfully emitted the set dose with 90% accuracy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding usedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used is present in the submitted article